News
News
- CRISPR Therapeutics Congratulates Co-Founder Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry
10/07/2020 / 15:25 - GlobeNewswire - CRISPR Therapeutics to Participate in Upcoming Investor Conferences
09/29/2020 / 14:00 - GlobeNewswire - Sarepta Therapeutics Reports Sustained Functional Improvement Two Years After Treatment with SRP-9001, its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
09/28/2020 / 14:55 - GlobeNewswire - Basilea starts phase 1/2 study FIDES-03 with derazantinib in patients with gastric cancer
09/28/2020 / 07:15 - GlobeNewswire - PTA-Adhoc: 4basebio AG: 4basebio AG signs term sheet for investment in nanoparticle-based gene therapy delivery technology
09/24/2020 / 16:15 - pressetext - Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies
09/23/2020 / 13:00 - GlobeNewswire - CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease
09/22/2020 / 15:00 - GlobeNewswire - Basilea reports data from poster presentations at ESMO Virtual Congress 2020
09/22/2020 / 07:15 - GlobeNewswire - BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
09/17/2020 / 10:00 - GlobeNewswire - Voyager Therapeutics Appoints Nancy Vitale to its Board of Directors
09/15/2020 / 22:01 - GlobeNewswire
Real-time